S&P 500   2,899.02 (-2.68%)
DOW   24,973.77 (-3.08%)
QQQ   201.90 (-1.82%)
AAPL   267.03 (-2.37%)
FB   186.01 (-1.97%)
GOOGL   1,288.02 (-2.05%)
AMZN   1,842.12 (-2.24%)
CGC   18.16 (-1.52%)
NVDA   258.30 (+2.26%)
BABA   199.77 (-2.57%)
MU   50.97 (+0.77%)
TSLA   631.76 (-6.96%)
AMD   43.90 (-0.25%)
T   34.64 (-3.05%)
ACB   1.35 (-6.90%)
F   6.82 (-2.15%)
NFLX   361.17 (-2.84%)
BAC   27.98 (-3.95%)
GILD   68.41 (-5.85%)
DIS   114.65 (-2.87%)
S&P 500   2,899.02 (-2.68%)
DOW   24,973.77 (-3.08%)
QQQ   201.90 (-1.82%)
AAPL   267.03 (-2.37%)
FB   186.01 (-1.97%)
GOOGL   1,288.02 (-2.05%)
AMZN   1,842.12 (-2.24%)
CGC   18.16 (-1.52%)
NVDA   258.30 (+2.26%)
BABA   199.77 (-2.57%)
MU   50.97 (+0.77%)
TSLA   631.76 (-6.96%)
AMD   43.90 (-0.25%)
T   34.64 (-3.05%)
ACB   1.35 (-6.90%)
F   6.82 (-2.15%)
NFLX   361.17 (-2.84%)
BAC   27.98 (-3.95%)
GILD   68.41 (-5.85%)
DIS   114.65 (-2.87%)
S&P 500   2,899.02 (-2.68%)
DOW   24,973.77 (-3.08%)
QQQ   201.90 (-1.82%)
AAPL   267.03 (-2.37%)
FB   186.01 (-1.97%)
GOOGL   1,288.02 (-2.05%)
AMZN   1,842.12 (-2.24%)
CGC   18.16 (-1.52%)
NVDA   258.30 (+2.26%)
BABA   199.77 (-2.57%)
MU   50.97 (+0.77%)
TSLA   631.76 (-6.96%)
AMD   43.90 (-0.25%)
T   34.64 (-3.05%)
ACB   1.35 (-6.90%)
F   6.82 (-2.15%)
NFLX   361.17 (-2.84%)
BAC   27.98 (-3.95%)
GILD   68.41 (-5.85%)
DIS   114.65 (-2.87%)
S&P 500   2,899.02 (-2.68%)
DOW   24,973.77 (-3.08%)
QQQ   201.90 (-1.82%)
AAPL   267.03 (-2.37%)
FB   186.01 (-1.97%)
GOOGL   1,288.02 (-2.05%)
AMZN   1,842.12 (-2.24%)
CGC   18.16 (-1.52%)
NVDA   258.30 (+2.26%)
BABA   199.77 (-2.57%)
MU   50.97 (+0.77%)
TSLA   631.76 (-6.96%)
AMD   43.90 (-0.25%)
T   34.64 (-3.05%)
ACB   1.35 (-6.90%)
F   6.82 (-2.15%)
NFLX   361.17 (-2.84%)
BAC   27.98 (-3.95%)
GILD   68.41 (-5.85%)
DIS   114.65 (-2.87%)
Log in

OTCMKTS:COTQF - Cotinga Pharmaceuticals Stock Price, Forecast & News

$0.04
+0.01 (+30.03 %)
(As of 02/28/2020 08:59 AM ET)
Today's Range
$0.04
Now: $0.04
$0.04
50-Day Range
$0.03
MA: $0.06
$0.08
52-Week Range
$0.01
Now: $0.04
$0.25
Volume200 shs
Average Volume823 shs
Market Capitalization$952,167.00
P/E RatioN/A
Dividend YieldN/A
Beta1.97
Cotinga Pharmaceuticals Inc, a biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, a clinical stage oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:COTQF
CUSIPN/A
CIKN/A
Phone860-798-0816

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.08) per share

Profitability

Net Income$-2,050,000.00

Miscellaneous

EmployeesN/A
Market Cap$952,167.00
Next Earnings Date4/6/2020 (Estimated)
OptionableNot Optionable

Receive COTQF News and Ratings via Email

Sign-up to receive the latest news and ratings for COTQF and its competitors with MarketBeat's FREE daily newsletter.


Cotinga Pharmaceuticals (OTCMKTS:COTQF) Frequently Asked Questions

What is Cotinga Pharmaceuticals' stock symbol?

Cotinga Pharmaceuticals trades on the OTCMKTS under the ticker symbol "COTQF."

How were Cotinga Pharmaceuticals' earnings last quarter?

Cotinga Pharmaceuticals Inc (OTCMKTS:COTQF) posted its earnings results on Friday, December, 27th. The company reported ($0.02) EPS for the quarter. View Cotinga Pharmaceuticals' Earnings History.

When is Cotinga Pharmaceuticals' next earnings date?

Cotinga Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Cotinga Pharmaceuticals.

Has Cotinga Pharmaceuticals been receiving favorable news coverage?

News articles about COTQF stock have trended extremely negative recently, InfoTrie reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cotinga Pharmaceuticals earned a media sentiment score of -4.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Cotinga Pharmaceuticals.

Who are some of Cotinga Pharmaceuticals' key competitors?

Who are Cotinga Pharmaceuticals' key executives?

Cotinga Pharmaceuticals' management team includes the folowing people:
  • Ms. Alison D. Silva, CEO, Pres & Director
  • Dr. Richard T. Ho, Chief Scientific Officer (Age 56)
  • Mr. Victor Hugo, Chief Financial Officer (Age 50)
  • Ms. Debi Sanderson MBA, Director of Resourcing & Operations
  • Mr. Paul Papi, VP of Investor Relations

How do I buy shares of Cotinga Pharmaceuticals?

Shares of COTQF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cotinga Pharmaceuticals' stock price today?

One share of COTQF stock can currently be purchased for approximately $0.04.

How big of a company is Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals has a market capitalization of $952,167.00. View Additional Information About Cotinga Pharmaceuticals.

What is Cotinga Pharmaceuticals' official website?

The official website for Cotinga Pharmaceuticals is http://coti.theyatesnetwork.com/.

How can I contact Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals' mailing address is 127 Main Street, Boston MA, 02129. The company can be reached via phone at 860-798-0816 or via email at [email protected]


MarketBeat Community Rating for Cotinga Pharmaceuticals (OTCMKTS COTQF)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  103 (Vote Outperform)
Underperform Votes:  145 (Vote Underperform)
Total Votes:  248
MarketBeat's community ratings are surveys of what our community members think about Cotinga Pharmaceuticals and other stocks. Vote "Outperform" if you believe COTQF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COTQF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: Depreciation

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel